CT
ABBV icon

Caldwell Trust’s AbbVie ABBV Stock Holding History

Caldwell Trust’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.55M Buy
25,513
+1,064
+4% +$236K 0.5% 50
2025
Q4 		$5.59M Sell
24,449
-540
-2% -$123K 0.5% 51
2025
Q3 		$5.79M Sell
24,989
-121
-0.5% -$24.6K 0.54% 46
2025
Q2 		$4.66M Buy
25,110
+759
+3% +$141K 0.47% 51
2025
Q1 		$5.1M Buy
24,351
+244
+1% +$47.4K 0.55% 42
2024
Q4 		$4.28M Sell
24,107
-1,356
-5% -$249K 0.45% 52
2024
Q3 		$5.03M Buy
25,463
+538
+2% +$100K 0.53% 44
2024
Q2 		$4.28M Sell
24,925
-487
-2% -$80.7K 0.47% 47
2024
Q1 		$4.63M Sell
25,412
-334
-1% -$57.6K 0.54% 45
2023
Q4 		$3.99M Sell
25,746
-3,033
-11% -$442K 0.5% 49
2023
Q3 		$4.29M Sell
28,779
-2,699
-9% -$396K 0.59% 44
2023
Q2 		$4.24M Buy
31,478
+145
+0.5% +$21.3K 0.55% 45
2023
Q1 		$4.99M Sell
31,333
-170
-0.5% -$26K 0.69% 39
2022
Q4 		$5.09M Sell
31,503
-1,975
-6% -$303K 0.72% 40
2022
Q3 		$4.49M Sell
33,478
-967
-3% -$139K 0.67% 41
2022
Q2 		$5.28M Sell
34,445
-278
-0.8% -$42.5K 0.73% 39
2022
Q1 		$5.63M Sell
34,723
-74
-0.2% -$10.7K 0.67% 39
2021
Q4 		$4.71M Sell
34,797
-232
-0.7% -$27.4K 0.54% 45
2021
Q3 		$3.78M Buy
35,029
+1,350
+4% +$154K 0.48% 50
2021
Q2 		$3.79M Sell
33,679
-208
-0.6% -$23.4K 0.5% 48
2021
Q1 		$3.67M Buy
33,887
+299
+0.9% +$32K 0.51% 47
2020
Q4 		$3.6M Buy
33,588
+575
+2% +$55.3K 0.54% 46
2020
Q3 		$2.89M Sell
33,013
-864
-3% -$81.3K 0.48% 52
2020
Q2 		$3.33M Buy
33,877
+511
+2% +$45K 0.56% 51
2020
Q1 		$2.54M Sell
33,366
-2,412
-7% -$205K 0.48% 56
2019
Q4 		$3.17M Buy
+35,778
New +$2.97M 0.48% 58

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Caldwell Trust's ABBV Position: Q1 2026 in Review

Caldwell Trust increased its AbbVie (ABBV) stake by 4.4% in Q1 2026, buying an estimated $236K and bringing the position to 25,513 shares worth $5.55M. The position accounts for 0.5% of the portfolio, ranked #50.

Caldwell Trust first reported a position in ABBV in Q4 2019 and has held it in 26 quarters since. The position peaked at $5.79M in Q3 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Caldwell Trust held 25,513 shares of AbbVie worth $5.55M as of Q1 2026.
  • Caldwell Trust bought 1,064 AbbVie shares in Q1 2026, an estimated $236K.
  • AbbVie made up 0.5% of Caldwell Trust's portfolio in Q1 2026, its #50 holding.
  • Caldwell Trust first reported a position in AbbVie in Q4 2019 and has held it in 26 quarters since.
  • Caldwell Trust's AbbVie position peaked at $5.79M in Q3 2025.
  • 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Caldwell Trust's 13F filing for Q1 2026, filed 22 Apr 2026.